Home / Prices / Corneal Collagen Cross-Linking

Corneal Collagen Cross-Linking

Eye Care estimated about CNY 8000-14000

Disclaimer: This site is a medical service platform; some page content is AI-assisted. Health-related information does not constitute medical advice. If you have any questions, please consult a healthcare professional. See full disclaimer

Description

A minimally invasive ophthalmic procedure that uses ultraviolet A light and riboflavin to strengthen corneal tissue, primarily treating keratoconus and corneal ectasia.

Main Uses

Primary clinical use is halting the progression of progressive keratoconus and other corneal ectasias (e.g., post-LASIK ectasia, pellucid marginal degeneration). It is indicated in patients with documented topographic and/or refractive progression, age ≥12 years, minimum corneal thickness ≥400 µm (epi-off) or ≥320 µm (epi-on/accelerated protocols), and adequate endothelial cell count. Also used off-label for infectious keratitis adjunctive therapy and selected cases of corneal ulcers resistant to conventional treatment.

Normal Range

Corneal Cross-Linking (CXL) is a therapeutic surgical procedure, not a diagnostic laboratory test; therefore, it has no numerical 'normal range' or quantitative biomarker values. Clinical success is assessed qualitatively and quantitatively via postoperative parameters such as corneal topography (e.g., maximum keratometry Kmax < 55 D, change ≤ 1.0 D/year), corneal thickness (>400 µm preoperatively for standard epithelium-off CXL), endothelial cell density (>2000 cells/mm²), and absence of ectasia progression over ≥2 years.

Low Values - Possible Causes

N/A — CXL is not a measurable lab value; however, suboptimal clinical outcomes ('low efficacy') may result from: 1) Preoperative corneal thickness <400 µm limiting riboflavin diffusion and UV absorption, 2) Inadequate UV-A irradiance (e.g., <3 mW/cm²) or duration (<30 min), 3) Epithelial non-removal or incomplete debridement in epithelium-off protocols, 4) Riboflavin solution degradation or insufficient stromal saturation, 5) Patient noncompliance with postoperative topical antibiotics/steroids leading to infection or haze.

High Values - Possible Causes

N/A — CXL is not a quantifiable test with high/low values; however, excessive or adverse effects ('high risk outcomes') may arise from: 1) UV-A overdose (irradiance >9 mW/cm² or exposure >30 min) causing endothelial damage or keratocyte apoptosis, 2) Excessive riboflavin concentration leading to oxidative stress beyond therapeutic window, 3) Preexisting severe corneal scarring or thinning (<300 µm) increasing perforation risk, 4) Concomitant use of photosensitizing medications enhancing UV toxicity, 5) Uncontrolled ocular surface disease (e.g., severe dry eye, active herpes keratitis) exacerbating postoperative inflammation.

corneal cross-linking keratoconus treatment corneal ectasia surgery riboflavin UV-A therapy corneal stabilization procedure

estimated about CNY 8000-14000